---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-004427"
form_type: "8-K"
ticker: "OLMA"
cik: "0001750284"
company_name: "Olema Pharmaceuticals, Inc."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T05:21:25.084867+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Olema exchanges ~6.07M shares for pre-funded warrants with Bain, Paradigm, BVF

## Summary
- Entered exchange agreements to swap 6,070,000 common shares for pre-funded warrants at $0.0001 exercise price.
- Exchange expected to close Jan 13, 2025; post-close outstanding shares estimated at 68,333,065.
- Warrants exercisable immediately; beneficial ownership capped at 9.99% (can be raised to 19.99% with notice).
- Issuance exempt from registration under Securities Act Section 3(a)(9); not a registered offering.

## SEC filing metadata
- accession: 0001193125-25-004427
- form_type: 8-K
- ticker: OLMA
- cik: 0001750284
- company_name: Olema Pharmaceuticals, Inc.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750284/000119312525004427/0001193125-25-004427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750284/000119312525004427/d915597d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-004427
- JSON: https://secwatch.observer/filing/0001193125-25-004427.json
- Plain text: https://secwatch.observer/filing/0001193125-25-004427.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.